找回密碼
 To register

QQ登錄

只需一步,快速開(kāi)始

掃一掃,訪問(wèn)微社區(qū)

打印 上一主題 下一主題

Titlebook: Hodgkin‘s and Non-Hodgkin‘s Lymphoma; John P. Leonard,Morton Coleman Book 2006 Springer-Verlag US 2006 Tumor.blood.bone.bone marrow.cell.d

[復(fù)制鏈接]
樓主: Awkward
41#
發(fā)表于 2025-3-28 18:26:28 | 只看該作者
,Monoclonal Antibodies in the Treatment of Non-Hodgkin’s Lymphoma,nally differentiate. Each lymphoma is derived from a lymphocyte that is frozen at a particular stage of development and often retains many of the immunophenotypic, morphologic, and molecular markers of the corresponding lymphocyte stage. Thus, lymphocyte development is well marked by the expression
42#
發(fā)表于 2025-3-28 22:41:41 | 只看該作者
,Blood and Bone Marrow Transplantation for Patients with Hodgkin’s and Non-Hodgkin’s Lymphoma, chemotherapy is often limited by hematopoetic toxicity. The realization that a significantly higher dose of chemotherapy or chemoradiotherapy could be delivered to a patient by reconstituting their marrow with hematopoetic stem cells paved the way to autologous blood or marrow transplantation (ABMT
43#
發(fā)表于 2025-3-29 02:27:21 | 只看該作者
,Vaccine Therapies for Non-Hodgkin’s Lymphomas,alities. Active immunotherapy, which attempts to harness the host’s own immune system to eradicate the malignant clone, has emerged as an important area of investigation in lymphoma. The attractiveness of this approach lies in the remarkable specificity of the adaptive immune system in recognizing t
44#
發(fā)表于 2025-3-29 06:04:52 | 只看該作者
45#
發(fā)表于 2025-3-29 09:12:34 | 只看該作者
,Nodular Lymphocyte Predominant Hodgkin’s Disease, subtypes.., . Although uncommon, approximately 5% of all HD, NLPHD is important because of its unique morphologic/immunophenotypic features, as well as its clinical characteristics and evolving recommendations for therapy.
46#
發(fā)表于 2025-3-29 15:08:25 | 只看該作者
Lymphoma Imaging: Nuclear Medicine,e (HD) and aggressive subtypes of non-Hodgkin’s lymphoma (NHL). The advent of more sensitive imaging modalities have increased staging and restaging accuracy and provided more effective means to evaluate response to therapy. In the post-therapy setting, the unnecessary use of aggressive chemotherapy
47#
發(fā)表于 2025-3-29 18:01:53 | 只看該作者
48#
發(fā)表于 2025-3-29 22:19:55 | 只看該作者
to the origin and interpretation of rainbow structure, diffraction oscillations and exchange oscillations in the potential scattering differential cross-section, and to the glory structure and symmetry oscillations in the integral cross-section. Available methods for direct inversion of the cross-s
49#
發(fā)表于 2025-3-30 03:05:43 | 只看該作者
50#
發(fā)表于 2025-3-30 07:34:55 | 只看該作者
 關(guān)于派博傳思  派博傳思旗下網(wǎng)站  友情鏈接
派博傳思介紹 公司地理位置 論文服務(wù)流程 影響因子官網(wǎng) 吾愛(ài)論文網(wǎng) 大講堂 北京大學(xué) Oxford Uni. Harvard Uni.
發(fā)展歷史沿革 期刊點(diǎn)評(píng) 投稿經(jīng)驗(yàn)總結(jié) SCIENCEGARD IMPACTFACTOR 派博系數(shù) 清華大學(xué) Yale Uni. Stanford Uni.
QQ|Archiver|手機(jī)版|小黑屋| 派博傳思國(guó)際 ( 京公網(wǎng)安備110108008328) GMT+8, 2025-10-6 20:04
Copyright © 2001-2015 派博傳思   京公網(wǎng)安備110108008328 版權(quán)所有 All rights reserved
快速回復(fù) 返回頂部 返回列表
宁南县| 鲁山县| 肇州县| 巴南区| 新河县| 庆阳市| 梧州市| 乡宁县| 贵港市| 陇南市| 汉沽区| 闵行区| 肇东市| 上饶市| 阿拉善右旗| 保亭| 玉树县| 铜川市| 乐平市| 醴陵市| 阿鲁科尔沁旗| 浑源县| 乌什县| 株洲市| 宾川县| 长治县| 宿迁市| 天峻县| 陆川县| 彝良县| 乌兰浩特市| 广宁县| 尼木县| 多伦县| 洛隆县| 天祝| 四平市| 平谷区| 鄄城县| 大同市| 鄂伦春自治旗|